BL PharmTech

BL PharmTech Current Assets

The Current Assets of BL PharmTech (065170.KQ) as of Oct 24, 2026 is 674.92 M KRW. In the previous year, Current Assets was 6.54 B KRW — a change of -89.69% (lower).

Current Assets

674.92 MKRW

YoY

-89.69%

Last updated:

Current Assets of BL PharmTech is 2025 674.92 M KRW. Current Assets of BL PharmTech was 2024 6.54 B KRW. It decreases by -89.69% lower compared to the previous year.

The BL PharmTech Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
54.03 B KRW
Jan 1, 2019
40.28 B KRW
Jan 1, 2020
34.49 B KRW
Jan 1, 2021
42.33 B KRW
Jan 1, 2022
32.33 B KRW
Jan 1, 2023
13.70 B KRW
Jan 1, 2024
6.54 B KRW
Jan 1, 2025
674.92 M KRW
The BL PharmTech Current Assets history
YEARCurrent AssetsYoY
674.92 MKRW-89.69%
6.54 BKRW-52.24%
13.70 BKRW-57.62%
32.33 BKRW-23.62%
42.33 BKRW+22.73%
34.49 BKRW-14.38%
40.28 BKRW-25.46%
54.03 BKRW+132.96%
23.19 BKRW-20.20%
29.07 BKRW+40.59%
20.67 BKRW+8.36%
19.08 BKRW+6.66%
17.89 BKRW-37.53%
28.64 BKRW-4.70%
30.05 BKRW-8.04%
32.67 BKRW+40.15%
23.31 BKRW-21.53%
29.71 BKRW+27.57%
23.29 BKRW+36.59%
17.05 BKRW-31.40%
24.86 BKRW+76.75%
14.06 BKRW-11.16%
15.83 BKRW-20.58%
19.93 BKRW+153.35%
7.87 BKRW+129.83%
3.42 BKRW+40.92%
2.43 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BL PharmTech Stock analysis

What does BL PharmTech do? BL PharmTech Corp generates revenue through four business segments. The Health Functional Food Business segment sells red ginsengs, diet foods, and vitamins. The Cosmetics Business segment offers anti-aging skincare products. The Diagnostic and Medical Business segment provides diagnostic kits and related products. The Other segment distributes health foods and other products. Customers include consumers seeking health supplements, skincare solutions, and medical diagnostic tools. The company targets health-conscious individuals and medical professionals who purchase these specialized products. The firm's revenue streams are derived from direct sales of manufactured goods across all segments. Red ginsengs, diet foods, and vitamins are sold under the Health Functional Food Business segment. Anti-aging skincare products come from the Cosmetics Business segment. Diagnostic kits and other medical products are sold through the Diagnostic and Medical Business segment. Distribution services for health foods form the Other segment's contribution to revenue. BL PharmTech Corp's customers primarily consist of end consumers for health functional foods and cosmetics, while medical institutions purchase diagnostic kits. The company's products are distributed through retail channels and direct sales to healthcare providers. Revenue is generated from the sale of manufactured items rather than licensing or subscription models. BL PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BL PharmTech stock

Current Assets of BL PharmTech is 674.92 M KRW in 2025.

Current Assets of BL PharmTech changed from 6.54 B KRW to 674.92 M KRW, representing a -89.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets BL PharmTech since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's BL PharmTech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — BL PharmTech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BL PharmTech